Your browser doesn't support javascript.
loading
Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
Sanchis-Gomar, Fabian; Lavie, Carl J; Morin, Daniel P; Perez-Quilis, Carme; Laukkanen, Jari A; Perez, Marco V.
Afiliação
  • Sanchis-Gomar F; Department of Physiology, Faculty of Medicine, INCLIVA Biomedical Research Institute, University of Valencia, Av. Blasco Ibáñez, 15, 46010, Valencia, Spain. fabian.sanchis@uv.es.
  • Lavie CJ; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA. fabian.sanchis@uv.es.
  • Morin DP; John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, USA.
  • Perez-Quilis C; John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, USA.
  • Laukkanen JA; Department of Physiology, Faculty of Medicine, INCLIVA Biomedical Research Institute, University of Valencia, Av. Blasco Ibáñez, 15, 46010, Valencia, Spain.
  • Perez MV; Institute of Clinical Medicine, Department of Medicine, University of Eastern Finland, Kuopio, Finland.
Am J Cardiovasc Drugs ; 20(5): 413-418, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32737841

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Arritmias Cardíacas / Infecções por Coronavirus / Pandemias / Betacoronavirus / Amiodarona Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Arritmias Cardíacas / Infecções por Coronavirus / Pandemias / Betacoronavirus / Amiodarona Idioma: En Ano de publicação: 2020 Tipo de documento: Article